PFIZER INC Deferred Income Taxes and Other Assets, Current
PFIZER INC (PFE) had Deferred Income Taxes and Other Assets, Current of $7.83 billion as of 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Deferred Income Taxes and Other Assets
us-gaap:DeferredIncomeTaxesAndOtherAssetsCurrent · last filed 2013-11-08
- 2013-09-29: Deferred Income Taxes and Other Assets, Current $7.83B.
- 2013-06-30: Deferred Income Taxes and Other Assets, Current $9.82B.
- 2013-03-31: Deferred Income Taxes and Other Assets, Current $9.65B.
- 2012-12-31: Deferred Income Taxes and Other Assets, Current $8.96B; Deferred Income Taxes and Other Assets, Current as first filed $9.20B.
| Period end | Deferred Income Taxes and Other Assets, Current | Deferred Income Taxes and Other Assets, Current as first filed |
|---|---|---|
| 2013-09-29 | $7.83B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $9.82B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $9.65B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $8.96B 10-Q · filed 2013-11-08 | $9.20B 10-K · filed 2013-02-28 |
| 2012-09-30 | $8.85B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $9.21B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $9.36B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $9.38B 10-K · filed 2013-02-28 | $9.44B 10-K · filed 2012-02-28 |
| 2011-10-02 | $9.29B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $9.27B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $8.76B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $9.44B 10-K · filed 2012-02-28 | $8.39B 10-Q · filed 2011-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |